0 hours
These are activities that expand general practice knowledge, skills and attitudes, related to your scope of practice.
0 hours
These are activities that require reflection on feedback about your work.
0 hours
These are activities that use your work data to ensure quality results.
These are activities that expand general practice knowledge, skills and attitudes, related to your scope of practice.
These are activities that require reflection on feedback about your work.
These are activities that use your work data to ensure quality results.
Is this the beginning of the end of the RACGP’s stranglehold on all things CPD?
A Bill, just passed by the House of Representatives, certainly seems to suggest so.
I know this newsletter is usually clinically-focussed but we think this development is too important to ignore.
The Bill (known by the catchy title the Health Insurance Amendment (General Practitioners and Quality Assurance) Bill 2020) paves the way for Medicare Services to say that if a GP is on the medical register they can access the higher Medicare rebates. No more getting the RACGP or ACRRM to report whether the GP has completed their triennium CPD requirements. If it’s good enough for AHPRA to register them it’s good enough for Medicare Services to pay them.
Parliament of Australia [Internet]. Canberra ACT: The Parliament of the Commonwealth of Australia, House of Representatives. Health Insurance Amendment (General Practitioners and Quality Assurance) Bill 2020: Explanatory Memorandum. 2019-2020. Available from: https://parlinfo.aph.gov.au/parlInfo/search/display/display.w3p;query=Id%3A%22legislation%2Fems%2Fr6505_ems_3eac2a60-e04f-4673-9ea5-e0768a2c7a07%22
Listen to expert interviews.
Click to open in a new tab
Browse the latest articles from Healthed.
Once you confirm you’ve read this article you can complete a Patient Case Review to earn 0.5 hours CPD in the Reviewing Performance (RP) category.
Select ‘Confirm & learn‘ when you have read this article in its entirety and you will be taken to begin your Patient Case Review.
Menopause and MHT
Multiple sclerosis vs antibody disease
Using SGLT2 to reduce cardiovascular death in T2D
Peripheral arterial disease
